Etoposide

colony stimulating factor 2 ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 19688296 Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model. 2010 Mar 1
2 16583432 Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis. 2006 May 1 1
3 16110137 Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma. 2005 1
4 14984497 Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. 2004 Feb 1
5 11398878 Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF. 2001 Apr 3
6 10450749 Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). 1999 Aug 2
7 9516141 BCR-ABL delays apoptosis upstream of procaspase-3 activation. 1998 Apr 1 2
8 9726444 A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer. 1998 Aug 1
9 9020283 Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832). 1997 Feb 4
10 9446257 [Low-dose GM-CSF and dose intensity of antineoplastic agents]. 1997 Sep-Oct 1
11 8602629 Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. 1996 Apr 2
12 8636749 Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. 1996 Feb 3
13 8826608 A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer. 1996 Jun 8
14 8913281 Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial. 1996 Oct 2
15 8960144 Granulocyte-macrophage-colony-stimulating factor support in patients with acute non-lymphatic leukemia. 1996 Nov-Dec 1
16 9152970 Tolerability and efficacy of GM-CSF [Leucomax] in patients with small cell lung cancer treated with intensive chemotherapy. 1996 Dec 1
17 7695978 A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy. 1995 1
18 7847254 A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma. 1995 Feb 1
19 7989942 Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma. 1994 Dec 1
20 8033046 A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies. 1994 Jul 15 1
21 8201386 Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. 1994 Jun 4
22 8209278 Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer. 1994 Jun 2
23 8445942 Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia. 1993 Mar 1
24 8457473 Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma. 1993 Feb 1
25 1280674 Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients. 1992 Dec 1
26 1306884 Use of GM-CSF in children after high-dose chemotherapy. 1992 1
27 4039984 Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma. 1985 1